Alpha Cognition Inc. (ACOG) stock
ACOGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3060% above fair value
$7.83−0.47 (-5.66%)
Close on Nov 16, 2026Market cap $170.52MP/E –Yield –
Alpha Cognition cash
Cash and short-term investments held at the end of each period.
Alpha Cognition's cash was $41.38M at Jun 30, 2026. For fiscal 2025 it was $66.05M, up 36.0% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $66.05M | +36.0% |
| FY2024 | Dec 31, 2024 | $48.56M | +3149.4% |
| FY2023 | Dec 31, 2023 | $1.49M | -28.3% |
| FY2022 | Dec 31, 2022 | $2.08M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $41.38M | +4.9% |
| Q1 FY2026 | Mar 31, 2026 | $54.25M | +18.9% |
| Q4 FY2025 | Dec 31, 2025 | $66.05M | +36.0% |
| Q3 FY2025 | Sep 30, 2025 | $35.40M | +838.1% |
| Q2 FY2025 | Jun 30, 2025 | $39.46M | +3204.7% |
| Q1 FY2025 | Mar 31, 2025 | $45.62M | +1782.8% |
| Q4 FY2024 | Dec 31, 2024 | $48.56M | +3149.4% |
| Q3 FY2024 | Sep 30, 2024 | $3.77M | +315.4% |
| Q2 FY2024 | Jun 30, 2024 | $1.19M | -1.9% |
| Q1 FY2024 | Mar 31, 2024 | $2.42M | +16.3% |
| Q4 FY2023 | Dec 31, 2023 | $1.49M | – |
| Q3 FY2023 | Sep 30, 2023 | $908.36K | – |
| Q2 FY2023 | Jun 30, 2023 | $1.22M | – |
| Q4 FY2022 | Dec 31, 2022 | $2.08M | – |
See a number that looks wrong?